Market Cap 338.88M
Revenue (ttm) 60,000.00
Net Income (ttm) -342.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -571,650.00%
Debt to Equity Ratio 0.00
Volume 19,600
Avg Vol 43,884
Day's Range N/A - N/A
Shares Out 19.21M
Stochastic %K 67%
Beta -0.07
Analysts Hold
Price Target $11.00

Company Profile

Lyell Immunopharma, Inc., a clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The company develops therapies using various approaches, such as c-Jun overexpression and NR4A3 gene knockout, to endow functional resistance to exhaustion; Epi-R to generate population of stem-like T cells with reduced exhaustion and improved proliferation and antitumor activity; CD62L positive enrichment...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 695 0677
Address:
201 Haskins Way, South San Francisco, United States
Hopipaytrader
Hopipaytrader Oct. 22 at 5:07 PM
$LYEL anyone see the overnight -25%
0 · Reply
Hopipaytrader
Hopipaytrader Oct. 22 at 3:25 AM
$LYEL ok deep handle time?
0 · Reply
Hopipaytrader
Hopipaytrader Oct. 17 at 12:28 PM
$LYEL good morning
0 · Reply
fantastex
fantastex Oct. 17 at 11:20 AM
$LYEL the big pump is yet to come.
0 · Reply
Hopipaytrader
Hopipaytrader Oct. 16 at 12:54 AM
$LYEL beauty
1 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 10:43 PM
Keep a close watch on CMCT! $INAB $OGEN $AGMH $LYEL 1
0 · Reply
fantastex
fantastex Oct. 6 at 8:03 PM
$LYEL if $SPRB went up 1600% this Company with breakthrough ph2/ph3 phase should go at 200$ overnight! Lol Such
0 · Reply
ObscureCandle
ObscureCandle Oct. 5 at 11:00 AM
$LYEL Biotech speculation. Pre-revenue stage. Chart shows high risk/reward. No pattern recognition.
1 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 3 at 12:44 AM
1 · Reply
Hopipaytrader
Hopipaytrader Oct. 1 at 1:41 PM
$LYEL shinkansen is leaving the station
1 · Reply
Latest News on LYEL
Lyell Immunopharma Completes Acquisition of ImmPACT Bio

Oct 31, 2024, 4:00 PM EDT - 1 year ago

Lyell Immunopharma Completes Acquisition of ImmPACT Bio


Lyell Immunopharma: Once Huge IPO Now Waiting For Clinical Data

Aug 26, 2023, 9:29 AM EDT - 2 years ago

Lyell Immunopharma: Once Huge IPO Now Waiting For Clinical Data


Hopipaytrader
Hopipaytrader Oct. 22 at 5:07 PM
$LYEL anyone see the overnight -25%
0 · Reply
Hopipaytrader
Hopipaytrader Oct. 22 at 3:25 AM
$LYEL ok deep handle time?
0 · Reply
Hopipaytrader
Hopipaytrader Oct. 17 at 12:28 PM
$LYEL good morning
0 · Reply
fantastex
fantastex Oct. 17 at 11:20 AM
$LYEL the big pump is yet to come.
0 · Reply
Hopipaytrader
Hopipaytrader Oct. 16 at 12:54 AM
$LYEL beauty
1 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 10:43 PM
Keep a close watch on CMCT! $INAB $OGEN $AGMH $LYEL 1
0 · Reply
fantastex
fantastex Oct. 6 at 8:03 PM
$LYEL if $SPRB went up 1600% this Company with breakthrough ph2/ph3 phase should go at 200$ overnight! Lol Such
0 · Reply
ObscureCandle
ObscureCandle Oct. 5 at 11:00 AM
$LYEL Biotech speculation. Pre-revenue stage. Chart shows high risk/reward. No pattern recognition.
1 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 3 at 12:44 AM
1 · Reply
Hopipaytrader
Hopipaytrader Oct. 1 at 1:41 PM
$LYEL shinkansen is leaving the station
1 · Reply
ASKING7
ASKING7 Sep. 30 at 8:20 PM
$LYEL nice move recently
0 · Reply
fantastex
fantastex Sep. 30 at 6:56 PM
$LYEL many sleepers on this. +200/300% move anytime
0 · Reply
Coach757
Coach757 Sep. 30 at 12:33 PM
$LYEL Is it true Bill Gates took a 5% position in this?
1 · Reply
Hopipaytrader
Hopipaytrader Sep. 25 at 12:40 AM
$LYEL terrible chart ;)
1 · Reply
fantastex
fantastex Sep. 24 at 2:31 PM
$LYEL 15+ next week.
0 · Reply
Malgo
Malgo Sep. 23 at 12:12 AM
$LYEL Monthly chart say 33.
0 · Reply
GMExAPE
GMExAPE Sep. 17 at 9:22 PM
RMFC stock has 5X potential, shorts at zero borrow and the 3m float is locked. Very undervalued here. - No dilution - Catalysts coming - Just reported record financials and added a new store a few weeks ago. $CATX $FTEK $ANIX $LIVE $LYEL www
0 · Reply
ultistock
ultistock Sep. 16 at 12:01 AM
$LYEL Merrill is not allowing me to buy or sell LYEL online due to market manipulation risks. Has anyone else experienced this issue?
1 · Reply
None_
None_ Sep. 3 at 9:49 PM
$LYEL $GILD $JNJ $BMY https://www.oncologypipeline.com/apexonco/lyell-needs-beat-breyanzi-and-yescarta
0 · Reply
BioTuesdays
BioTuesdays Sep. 3 at 3:25 PM
$LYEL initiates Phase 3 CAR T-cell therapy trial in R/R LBCL; forms expert steering committee https://biotuesdays.com/2025/09/03/lyell-initiates-phase-3-car-t-cell-therapy-trial-in-r-r-lbcl-forms-expert-steering-committee/
0 · Reply
fantastex
fantastex Aug. 20 at 1:21 PM
$LYEL promising pipeline at only 200m market cap with 290m cash + 50m from private placement? Low cash burn around 42m per quarter. Whoever sees good results here will takeover the company 100% for 5/6x current price (55 dollars minimum). Undervalued af.
0 · Reply
Revaluation
Revaluation Aug. 18 at 5:26 PM
$LYEL From the looks of it - stock is not liquid enough to make any large purchases without shooting up the SP. big boys/friends/family wanted in at this discount so they went with a private placement. They didn’t need money, especially raising at this low price… odd
1 · Reply